mouse anti pax8 (Santa Cruz Biotechnology)
Structured Review
Mouse Anti Pax8, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti pax8/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation"
Article Title: PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation
Journal: Cell reports
doi: 10.1016/j.celrep.2021.109747
Figure Legend Snippet: (A) Endogenous PBRM1 was immunoprecipitated (IP) from human embryonic kidney cells (HEK293, left) and RCC cells (ACHN, right), and co-purified proteins were analyzed by LCMS/MS. Shown are identified coactivator (CoA) components and transcription factors. Circle size indicates abundance of protein in the interactome. A minimum Mascot ion score of 25 and peptide rank 1 were used for automatically accepting all peptide MS/MS spectra. The most enriched functional group was “ATPase chromatin remodeling complex” (p value Bonferroni-corrected 1.42 × 10 −27 ). The STRING database system was used to construct the protein-protein interaction network with a parameter STRONG score >0.4. Detection, quantification, Gene Ontology (GO), and STRING data for these and other proteins are in . Heatmap shows quantification versus IP with immunoglobulin G (IgG) isotype control. (B) Heatmap summary of the data shown in (A). (C) Bi-directional IP-western blots in 293T and three RCC cell lines confirmed the interaction between PBRM1 and PAX8. The RCC cell lines used were ACHN, SKRC45, and SKRC29.
Techniques Used: Immunoprecipitation, Purification, Tandem Mass Spectroscopy, Functional Assay, Construct, Western Blot
Figure Legend Snippet: (A) Endogenous PAX8 was IP from PBRM1-deficient RCC cells (SKRC-45 with deletion of a PBRM1 allele), and coregulator interactions were analyzed by LCMS/MS. A minimum Mascot ion score of 25 and peptide rank 1 were used for automatically accepting all peptide MS/MS spectra. By GO analyses, the most enriched protein functional groups were the NURD and CBX corepressor(CoR) complexes (p value Bonferroni corrected 3.47 × 10 −29 ). STRING was used to construct the protein-protein interaction network with a STRONG score >0.4. Circle size indicates abundance of protein in the interactome. Detection, quantification data, GO, and STRING analyses data are in . Heatmap shows quantification versus IP with IgG isotype control. (B) Endogenous PAX8 was IP from PBRM1-deficient RCC cells (ACHN with mutation of a PBRM1 allele) and coregulator interactions analyzed by LCMS/MS. Analyses as described for (A).
Techniques Used: Tandem Mass Spectroscopy, Functional Assay, Construct, Mutagenesis
Figure Legend Snippet: (A) The analysis approach. (B) Copy numbers of genes for components of the PBAF CoA and for druggable CoR components recruited by PAX8. Gistic thresholded copy-number data from TCGA (n = 342). (C) The copy-number alterations (predominantly deletions) and inactivating mutations to genes for PBAF CoA components impact their expression accordingly. Gene expression in normal kidney (NKid) and RCCs stratified by recurrent deletions and mutations of CoA genes (RNA sequencing [RNA-seq] TCGA, NKid cortex n = 72, RCC n = 342). Median ± interquartile range (IQR). *p < 0.001, two-sided Mann-Whitney test. (D) The copy-number alterations to genes for druggable CoR components (predominantly gains/amplifications) impact their expression accordingly. Gene expression in NKid and RCCs stratified by recurrent gains/amplifications of CoR genes (RNA-seq TCGA, NKid cortex n = 72, RCC n = 342). Median ± IQR. *p < 0.001, two-sided Mann-Whitney test.
Techniques Used: Expressing, RNA Sequencing Assay, MANN-WHITNEY
Figure Legend Snippet: (A) The proximal tubule core transcription factor circuit . (B) PAX8 localizes at regulatory regions of GATA3 , LHX1 , and WT1 . Chromatin IP (ChIP)-qRT-PCR analyses using α-PAX8 and IgG isotype control; primers amplified proximal promoter regions. Mean + SD for three biological replicates. Two-sided unpaired t test. (C) Selective loss in RCC (CAKI1)of H3K27Ac but not H3K4me3 at key PAX8 transcription factor target-genes ( GATA3 , LHX1 , and WT1 ; red boxes). NKid, normal kidney. H3K27Ac and H3K4me3 public ChIP-seq data (Encode and E-MTAB-7812; ). (D) GATA3 / LHX1 / WT1 are least activated in RCCs with biallelic PBRM1 inactivation (Del+Mut, deletion and mutation). NKid n = 72, RCC with PBRM1 Del n = 256, RCC with PBRM1 Del+Mut n = 180 (TCGA, RNA-seq). Boxplot = median ± IQR, whiskers = range. *p < 0.001, #p < 0.05, two-sided Mann-Whitney test. (E) GATA3 / LHX1 / WT1 CpG methylation is greatest in RCCs with PBRM1 Del+Mut. CpG numbers at each gene: PAX2 , 49; PAX8 , 16; GATA3 , 28; LHX1 , 31; and WT1 , 46. NKid n = 160, RCC with PBRM1 Del n = 74, RCC with PBRM1 Del+Mut n = 64 (TCGA, 450K Illumina array). (F) >1,000 proximal tubule genes (kidney epithelial genes) are consistently suppressed in RCCs versus NKid. Genes identified from kidney development and normal tissues gene expression databases. Two-sided unpaired t test for average expression/gene NKid versus RCCs. (G) H3K27Ac but not H3K4me3 loss at repressed proximal tubule genes (F); ChIP-seq per (C). Two-sided unpaired t test, average ChIP-seq values/gene.
Techniques Used: Chromatin Immunoprecipitation, Quantitative RT-PCR, Amplification, ChIP-sequencing, Mutagenesis, RNA Sequencing Assay, MANN-WHITNEY, CpG Methylation Assay, Expressing
Figure Legend Snippet: (A) The experimental approach. (B) Western blot and IP-western blot analyses of empty vector versus FLAG-PBRM1 transfected RCC (ACHN) cells. PAX8 versus IgG control IP was performed in lysates from empty vector versus PBRM1-FLAG transfected cells 48 h after transfection. (C) Heatmaps to indicate amounts of coregulators in the PAX8 interactome in empty vector versus FLAG-PBRM1 transfected cells. PAX8 was IP and proteins analyzed by LCMS/MS. Analyses were 48 h after transfection. A minimum Mascot ion score of 25 and peptide rank 1 were used for automatically accepting all peptide MS/MS spectra. STRING was used to construct the protein-protein interaction network with a STRONG score >0.4. Circle size indicates abundance of protein in the interactome. Detection, quantification, GO, and STRING analyses data are in . (D) Relative abundances of CoA and CoR complexes with empty vector versus PBRM1 transfection. The individual proteins constituting CoA and CoR are listed in (A). Median ± IQR. Values analyzed are tabulated in .
Techniques Used: Western Blot, Plasmid Preparation, Transfection, Tandem Mass Spectroscopy, Construct
Figure Legend Snippet: (A) The experimental approach. (B) Heatmaps compare amounts of coregulators in the endogenous PAX8 interactome in vehicle versus Dec-treated RCC cells (SKRC-45). LCMS/MS analyses of proteins pulled down by PAX8 IP. Vehicle or Dec 0.5 μM added on days 1 and 2 and analyses done on day 3. A minimum Mascot ion score of 25 and peptide rank 1 were used for automatically accepting all peptide MS/MS spectra. STRING was used to construct the protein-protein interaction network with a STRONG score >0.4. Circle size indicates abundance of protein in the interactome. Detection, quantification data, GO, and STRING analyses data are in . (C) Relative abundances of specific CoA (green) and CoR (red) complexes with vehicle versus Dec treatment. The individual proteins constituting each complex are listed in (B). Median ± IQR. Values analyzed are tabulated in . (D) Western blot and IP-western blot analysis of the PAX8 protein hub in vehicle versus Dec-treated RCC cells. PAX8 versus IgG control IP in lysates from vehicle, Dec, and camptothecin 10 μM (CP, as conventional chemotherapy control) treated RCC (SKRC-45) cells.
Techniques Used: Tandem Mass Spectroscopy, Construct, Western Blot
Figure Legend Snippet: KEY RESOURCES TABLE
Techniques Used: Recombinant, Protease Inhibitor, DNA Purification, Software